160 related articles for article (PubMed ID: 30881493)
21. A novel ubiquitin ligase is deficient in Fanconi anemia.
Meetei AR; de Winter JP; Medhurst AL; Wallisch M; Waisfisz Q; van de Vrugt HJ; Oostra AB; Yan Z; Ling C; Bishop CE; Hoatlin ME; Joenje H; Wang W
Nat Genet; 2003 Oct; 35(2):165-70. PubMed ID: 12973351
[TBL] [Abstract][Full Text] [Related]
22. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
[TBL] [Abstract][Full Text] [Related]
23. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.
Brekelmans CT; Tilanus-Linthorst MM; Seynaeve C; vd Ouweland A; Menke-Pluymers MB; Bartels CC; Kriege M; van Geel AN; Burger CW; Eggermont AM; Meijers-Heijboer H; Klijn JG
Eur J Cancer; 2007 Mar; 43(5):867-76. PubMed ID: 17307353
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Fanconi anemia protein FANCD2 monoubiquitination by miR-302.
Suresh B; Kumar AM; Jeong HS; Cho YH; Ramakrishna S; Kim KS
Biochem Biophys Res Commun; 2015 Oct; 466(2):180-5. PubMed ID: 26343459
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer.
Zhu QY; Li PC; Zhu YF; Pan JN; Wang R; Li XL; Ye WW; Ding XW; Wang XJ; Cao WM
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14303-14313. PubMed ID: 37566130
[TBL] [Abstract][Full Text] [Related]
28. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
29. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability.
Howlett NG; Taniguchi T; Durkin SG; D'Andrea AD; Glover TW
Hum Mol Genet; 2005 Mar; 14(5):693-701. PubMed ID: 15661754
[TBL] [Abstract][Full Text] [Related]
30. Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.
Ansquer Y; Mandelbrot L; Lehy T; Salomon L; Dhainaut C; Madelenat P; Feldmann G; Walker F
Anticancer Res; 2005; 25(6C):4535-41. PubMed ID: 16334138
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
32. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.
Vilcheck SK; Ceryak S; O'Brien TJ; Patierno SR
Mutat Res; 2006 Nov; 610(1-2):21-30. PubMed ID: 16893675
[TBL] [Abstract][Full Text] [Related]
33. Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines.
Burkitt K; Ljungman M
Cancer Lett; 2007 Aug; 253(1):131-7. PubMed ID: 17321670
[TBL] [Abstract][Full Text] [Related]
34. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
35. FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia.
Hölzel M; van Diest PJ; Bier P; Wallisch M; Hoatlin ME; Joenje H; de Winter JP
J Pathol; 2003 Oct; 201(2):198-203. PubMed ID: 14517836
[TBL] [Abstract][Full Text] [Related]
36. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
37. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
[TBL] [Abstract][Full Text] [Related]
38. Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.
Whiteaker JR; Zhao L; Ivey RG; Sanchez-Bonilla M; Moore HD; Schoenherr RM; Yan P; Lin C; Shimamura A; Paulovich AG
DNA Repair (Amst); 2018 May; 65():47-53. PubMed ID: 29605812
[TBL] [Abstract][Full Text] [Related]
39. Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.
Federico MB; Campodónico P; Paviolo NS; Gottifredi V
Mutat Res; 2018 Mar; 808():83-92. PubMed ID: 29031493
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex.
Cheung RS; Castella M; Abeyta A; Gafken PR; Tucker N; Taniguchi T
Cell Rep; 2017 Jun; 19(12):2432-2440. PubMed ID: 28636932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
